Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness

Journal of Applied Physiology - Tập 102 Số 4 - Trang 1313-1322 - 2007
David E. Leaf, David S. Goldfarb1
1New York University

Tóm tắt

Acetazolamide, a potent carbonic anhydrase (CA) inhibitor, is the most commonly used and best-studied agent for the amelioration of acute mountain sickness (AMS). The actual mechanisms by which acetazolamide reduces symptoms of AMS, however, remain unclear. Traditionally, acetazolamide's efficacy has been attributed to inhibition of CA in the kidneys, resulting in bicarbonaturia and metabolic acidosis. The result is offsetting hyperventilation-induced respiratory alkalosis and allowance of chemoreceptors to respond more fully to hypoxic stimuli at altitude. Studies performed on both animals and humans, however, have shown that this explanation is unsatisfactory and that the efficacy of acetazolamide in the context of AMS is likely due to a multitude of effects. This review summarizes the known systemic effects of acetazolamide and incorporates them into a model encompassing several factors that are likely to play a key role in the drug's efficacy. Such factors include not only metabolic acidosis resulting from renal CA inhibition but also improvements in ventilation from tissue respiratory acidosis, improvements in sleep quality from carotid body CA inhibition, and effects of diuresis.

Từ khóa


Tài liệu tham khảo

10.1113/jphysiol.1990.sp017939

10.1164/ajrccm/145.4_Pt_1.817

10.1152/jappl.1971.31.3.363

Arieff AI, Kerian A, Massry SG, DeLima J.Intracellular pH of brain: alterations in acute respiratory acidosis and alkalosis.Am J Physiol230: 804–812, 1976.

10.1038/sj.jcbfm.9600169

10.1183/09031936.95.08010062

10.1016/0952-0600(90)90046-L

10.1089/ham.2006.7.17

10.1113/jphysiol.1989.sp017578

10.1152/jappl.1988.65.1.428

Birmingham Medical Research Expeditionary Society Mountain Sickness Study Group.Acetazolamide in control of acute mountain sickness.Lancet1: 180–183, 1981.

10.1113/jphysiol.1970.sp009109

Brookfield DS, Liston WA, Brown GV.Use of spironolactone in the prevention of acute mountain sickness on Kilimanjaro.East Afr Med J54: 689–691, 1977.

Brown GV, Liston WA, Brookfield DSK.Spironolactone in acute mountain sickness.Lancet1: 855, 1977.

10.1152/jappl.1965.20.5.882

10.1152/jappl.1966.21.4.1195

10.1152/jappl.1998.84.2.683

10.1113/jphysiol.1991.sp018760

Collier DJ, Nathan J, Flower RJ, Wolff CB, Swenson ER, Milledge JS.Benzolamide, a selective carbonic anhydrase inhibitor, prevents acute mountain sickness: possible mechanisms. In:Hypoxia: Women at Altitude, edited by Houston CS and Coates G. Burlington, VT: Queen City Printers, 1997, p. 307.

Currie TT.Spironolactone and acute mountain sickness.Med J Aust19: 419–420, 1977.

Currie TT, Carter PH, Champion WL, Fong G, Francis JK, McDonald IH, Newing RK, Nunn IN, Sisson RN, Sussex M, Zacharin RF.Spironolactone and acute mountain sickness.Med J Aust2: 168–170, 1976.

10.1001/archneur.1961.00450140109011

10.1164/ajrccm.154.6.8970365

10.1111/j.1468-2982.2004.00619.x

10.1152/ajpheart.1990.258.4.H954

Fujimoto K, Matsuzawa Y, Hirai K, Yagi H, Fukushima M, Shibamoto T, Koyama S, Levine BD, Kobayashi T.Irregular nocturnal breathing patterns high altitude in subjects susceptible to high-altitude pulmonary edema (HAPE): a preliminary study.Aviat Space Environ Med60: 786–791, 1989.

10.1073/pnas.89.15.6823

10.1055/s-2007-1024586

10.7326/0003-4819-116-6-461

10.1159/000016027

10.1016/S0140-6736(76)91677-9

10.1055/s-2007-1011443

10.1159/000194501

10.1089/1527029041352054

10.1164/arrd.1987.135.4.896

10.1113/jphysiol.1981.sp013938

10.1016/0034-5687(79)90043-4

10.1152/jappl.1976.40.4.559

Hayes MW, Maini BK, Torrance RW.Reduction of the responses of carotid chemoreceptors by acetazolamide. In:Morphology and Mechanisms of Arterial Chemoreceptors, edited by Paintal AS. Delhi, India: Vallabhbhai Patel Chest Institute University, 1976, p. 36–47.

Heinemann H, Goldring R.Bicarbonate and the regulation of ventilation.Am J Med57: 370, 1974.

10.1152/ajpregu.1989.257.6.R1282

10.1016/0034-5687(88)90090-4

10.1152/jappl.1980.48.2.355

10.1152/jappl.1993.75.4.1587

10.1161/01.CIR.97.21.2154

10.1152/jappl.1984.57.1.85

10.1053/smrv.2001.0223

10.1001/archinte.1970.00310040073007

10.1152/jappl.1977.42.5.667

10.1016/0034-5687(76)90032-3

10.1164/ajrccm.163.2.9911075

Klocke RA.Potential role of endothelial carbonic anhydrase in dehydration of plasma bicarbonate.Trans Am Clin Climatol Assoc108: 44–58, 1996.

Kronenberg RS, Cain SM.Hastening respiratory acclimatization to altitude with benzolamide (CL 11,366).Aerospace Med39: 296–300, 1968.

10.1016/0034-5687(79)90096-3

10.1016/0034-5687(83)90086-5

10.1152/jappl.1981.51.1.55

10.1016/0006-8993(82)90478-4

10.1001/jama.1982.03330030034021

10.1111/j.1475-097X.1990.tb00792.x

10.1136/pgmj.63.737.185

Lee KD, Mattenheimer H.The biochemistry of the carotid body.Enzymol Biol Clin (Basel)10: 199–216, 1964.

10.1007/BF00362215

Linton RA, Poole-Wilson PA, Davies RJ, Cameron IR.A comparison of the ventilatory response to carbon dioxide by steady-state and rebreathing methods during metabolic acidosis and alkalosis.Clin Sci Mol Med Suppl42: 239–249, 1973.

10.1152/japplphysiol.00527.2004

Loeschcke HH, Gertz KH.Einfluss des O2-Druckes in der Einatmungsluft auf die Atemtatigkeit der Menschen, gepruft unter Konstanthaltung des alveolaren CO2-Druckes.Pflügers Arch Ges Physiol267: 477, 1958.

10.1152/physrev.1967.47.4.595

10.1152/jappl.1979.47.3.471

10.2170/jjphysiol.39.523

McCloskey DI.Carbon dioxide and the carotid body. In:Arterial Chemoreceptors, edited by Torrance RW. Oxford: Blackwell, 1968, p. 101–133.

Messeter K.The effect of acetazolamide upon the regulation of the cerebrospinal fluid pH in the rat.Acta Physiol Scand85: 58–70, 1972.

10.1152/jappl.1963.18.3.523

10.1016/0034-5687(83)90116-0

Normand H, Barragan M, Benoit O, Bailliart O, Raynaud J.Periodic breathing and O2saturation in relation to sleep stages at high altitude.Aviat Space Environ Med61: 229–235, 1990.

10.1159/000064276

Phillipson EA.Control of breathing during sleep.Am Rev Respir Dis118: 909–939, 1978.

10.1016/0013-4694(75)90188-1

10.1111/j.1749-6632.1984.tb12363.x

10.1580/0953-9859-5.1.34

10.1007/BF00489979

10.1113/jphysiol.1991.sp018441

Roach RC, Hackett PH.Frontiers of hypoxia research: acute mountain sickness.J Exp Biol204: 3161–3170, 2001.

Roth LJ, Schoolar JC, Barlow CF.Sulfur-35 labeled acetazolamide in cat brain.J Pharmacol Exp Ther125: 128–136, 1959.

10.1183/09031936.98.12020408

10.1016/0034-5687(66)90049-1

10.1056/NEJM196901232800402

10.1164/arrd.1983.127.4.405

10.1139/y03-056

Sundstrom ES.Studies on adaptation of man to high altitudes. V. Effect of high altitudes on salt metabolism.Univ Calif Publ Physiol5: 121–132, 2006.

Sutton J.Acute mountain sickness. An historical review, with some experiences from the Peruvian Andes.Med J Aust2: 243–248, 1971.

10.1056/NEJM197912133012406

10.1183/09031936.98.12061242

10.1016/j.resp.2005.10.011

Swenson ER.High-altitude diuresis: fact or fancy. In:Hypoxia: Women at Altitude, edited by Houston CS and Coates G. Burlington VT: Queen City Printers, 2006, p. 272–283.

10.1152/jappl.1995.78.2.377

10.1152/jappl.1993.74.1.230

10.1016/0034-5687(91)90104-Q

10.1016/0034-5687(78)90018-X

10.1113/jphysiol.2006.110528

10.1164/ajrccm.160.5.9903088

10.1016/0034-5687(88)90044-8

10.2170/jjphysiol.36.511

Torrance RW.Arterial chemoreceptors. In:Respiratory Physiology, edited by Widdicombe JG. Baltimore, MD: University Park Press, 1974, p. 247–271.

10.1007/978-1-4615-9035-4_16

Travis DM.Molecular CO2is inert on carotid chemoreceptor: demonstration by inhibition of carbonic anhydrase.J Pharmacol Exp Ther178: 529–540, 1971.

10.1007/978-1-4684-4895-5_34

Vardy J, Vardy J, Judge K.Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.Aviat Space Environ Med77: 742–744, 2006.

Vogh BP, Maren TH.Sodium, chloride, and bicarbonate movement from plasma to cerebrospinal fluid in cats.Am J Physiol228: 673–683, 1975.

10.1172/JCI111579

Vos PJ, Folgering HT, de Boo TM, Lemmens WJ, van Herwaarden CL.Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD).Eur Respir J7: 850–855, 1994.

Vovk A, Duffin J, Kowalchuk JM, Paterson DH, Cunningham DA.Changes in chemoreflex characteristics following acute carbonic anhydrase inhibition in humans at rest.Exp Physiol85: 847–856, 2000.

10.1113/jphysiol.1996.sp021587

Weil JV, Kryger MH, Scoggin CH.Sleep and breathing at high altitude. In:Sleep Apnea Syndromes.New York: Liss, 1978, p. 119–123.

Weil JV.Sleep at high altitude. In:Principles and Practice of Sleep Medicine, edited by Kryger MH, Roth T, and Dement WC. Philadelphia, PA: Saunders, 1989, p. 269–275.

10.1089/1527029041352162

West JB.High Life: A History of High-Altitude Physiology and Medicine.New York: Oxford University Press, 1998.

10.7326/0003-4819-141-10-200411160-00010

10.1007/s11325-999-0089-1

10.1089/15270290050502408